CADTH Reimbursement Review - Finerenone (Kerendia) - Sponsor: Bayer Inc. Therapeutic area: Chronic kidney disease

Canadian Agency for Drugs and Technologies in Health

Share artifact

Or copy link:

Register Login

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Add to list

You have no lists yet

Manage lists

Citation

Health, C., 2023. CADTH Reimbursement Review - Finerenone (Kerendia) - Sponsor: Bayer Inc. Therapeutic area: Chronic kidney disease, Canadian Agency for Drugs and Technologies in Health. Canada. Retrieved from https://canadacommons.ca/artifacts/3897883/cadth-reimbursement-review-finerenone-kerendia-sponsor/4704209/ on 25 Apr 2024. CID: 20.500.12592/2sz375.

Download citation (RIS)

Full-page Screenshot

Screenshot of https://coherent-commons.s3.amazonaws.com/artifacts/file/file/502b7cb3-cc3c-4472-9072-c9b2dc7ce1e1.pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA23B6R4NTCRHS5NZ3%2F20240425%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20240425T220944Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=9f814d4b332580773ac4cb3b1378b53753a6de8d9f09a4076c531ce1d8ecd77c

CADTH Reimbursement Review - Finerenone (Kerendia) - Sponsor: Bayer Inc. Therapeutic area: Chronic kidney disease

Authors

Tables

Share artifact

Add to list

Citation

Full-page Screenshot